For all the latest GLP-1RA-related articles and resources published by JACC, visit JACC's Obesity Hub
The risk emerges when appetite suppression leads to inadequate nutrition, particularly protein deficiency that results in muscle loss rather than fat loss
A permanent, scarring type of hair loss, and an autoimmune type called alopecia areata, showed no clear link to the drugs
"Providing a treatment option that is proven to lower this cardiovascular risk is a major advance for public health ." Wegovy, which is made by Denmark-based Novo Nordisk, is a glucagon-like peptide-1 (GLP-1) receptor agonist that should not be taken with other semaglutide or GLP-1 products, the FDA stated
Your healthcare provider may recommend pausing at your current dose for an additional week or two before increasing, allowing your system to acclimate fully
10.3389/fimmu.2024.1432799 Front Immunol